Conrrad Nicholls is Director of Virology at Eradivir, Inc., where he leads a team advancing antiviral therapeutics targeting RSV, HIV, and dengue from early discovery through clinical development. His research centers on the application of bispecific antigenic immunotherapies (BAiTs)  – molecules that recruit the body’s own immune system for targeted clearance – to the field of infectious diseases. His efforts have produced 7 patents, a robust preclinical dengue program, and an RSV program that was advanced from concept to preclinical toxicology in under 24 months.

Conrrad holds a PhD in Structural Virology and an MPH from Purdue University, and a BS in Biology from Indiana State University, where he was a Division I defensive end and three-year team captain. He brings the same drive for excellence and team-first mentality from the football field to the lab, with a deep commitment to scientific rigor and mentoring the next generation of researchers.